Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2

Despite remarkable progress in the development and authorization of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is a need to validate vaccine platforms for broader application. The current intramuscular vaccines are designed to elicit systemic immunity withou...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Xingyue, Martinez-Paniagua, Melisa, Rezvan, Ali, Sefat, Samiur Rahman, Fathi, Mohsen, Singh, Shailbala, Biswas, Sujit, Pourpak, Melissa, Yee, Cassian, Liu, Xinli, Varadarajan, Navin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388188/
https://www.ncbi.nlm.nih.gov/pubmed/34462731
http://dx.doi.org/10.1016/j.isci.2021.103037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388188/
https://www.ncbi.nlm.nih.gov/pubmed/34462731
http://dx.doi.org/10.1016/j.isci.2021.103037

Ejemplares similares